Seeking Alpha

Elan (ELN) CEO Kelly Martin, who planned to step down May 1, will stay on the job until data is...

Elan (ELN) CEO Kelly Martin, who planned to step down May 1, will stay on the job until data is published from late-stage clinical trials of an experimental Alzheimer’s drug. The results on the drug are “potentially of transformational significance," says Chairman Robert Ingram in a statement released this morning.
Comments (1)
  • richwolol
    , contributor
    Comments (13) | Send Message
     
    It's time for this loser to leave. He has been an anchor for Elan for as long as he has been there.....Perhaps it's time for the Bd of Directors to remove him since he will not leave.....
    1 Mar 2012, 11:55 AM Reply Like
DJIA (DIA) S&P 500 (SPY)